SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ChemTrak
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kip518 who wrote (34)10/23/1996 10:15:00 AM
From: William Presti   of 48
 
The demand for Cholestrak will have to be evaluated over a period of several quarters by the retail merchants so they can correctly gauge how much to order. Since most of them greatly overordered the product last year when it was being marketed by J&J, the opposite happened this year when it was reintroduced. For example, I know that our local supermarket's drug department opted to go cautiously when ordering the product. What happened was that they ended up selling out and customers had to wait a couple of weeks until a new shipment got in. While the sales of Cholestrak will ebb and flow throughout the year, they really should not decline. It is really a great product (I've tried it myself) and there is lots of interest in the consumer market for it. The decline in the 3rd quarter is probably related more to supply being temporarily out of wack with demand. We'll see. Also, when cholesterol reducing drugs are approved for OTC sales, Cholestrak sales should get pulled along for the ride.

BTW, this discussion/investor group/thread on CMTR is getting more interesting, Wouldn't you say? Wish I had a crystal ball to see how Hp Chek will impact the bottom line at CMTR. Since it will be marketed with what is expected to be the world best selling drug Prilosec/Losec, I would expect very good results.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News